1. |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
|
2. |
刘杰, 赵田, 李钦传, 等. 肺癌免疫治疗进展. 中国胸心血管外科临床杂志, 2022, 29(11): 1517-1524.
|
3. |
潘汉博, 罗清泉. α7烟碱型乙酰胆碱受体在肺癌中作用的研究进展. 中国胸心血管外科临床杂志, 2023, 30(6): 917-923.
|
4. |
Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol, 2015, 10(9): 1243-1260.
|
5. |
Woo W, Yang YH, Cha YJ, et al. Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea. Thorac Cancer, 2022, 13(23): 3310-3321.
|
6. |
Zheng M, Hu Y, Gou R, et al. Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma. Aging (Albany NY), 2019, 11(12): 4198-4215.
|
7. |
孙思颖, 李鹤成. 人工智能联合组学数据在非小细胞肺癌诊疗中的研究进展. 中国胸心血管外科临床杂志, 2023, 30(2): 305-312.
|
8. |
徐嘉昕, 钱凯, 蒋立虹. 机器学习算法在肺癌临床诊断及生存预后分析中的应用. 中国胸心血管外科临床杂志, 2022, 29(6): 777-781.
|
9. |
Szalontai K, Gémes N, Furák J, et al. Chronic obstructive pulmonary disease: Epidemiology, biomarkers, and paving the way to lung cancer. J Clin Med, 2021, 10(13): 2889.
|
10. |
Stipp MC, Acco A. Involvement of cytochrome P450 enzymes in inflammation and cancer: A review. Cancer Chemother Pharmacol, 2021, 87(3): 295-309.
|
11. |
Zeng Y, Lv X, Du J. Natural killer cell-based immunotherapy for lung cancer: Challenges and perspectives (Review). Oncol Rep, 2021, 46(5): 232.
|
12. |
Souza-Fonseca-Guimaraes F, Cursons J, Huntington ND. The emergence of natural killer cells as a major target in cancer immunotherapy. Trends Immunol, 2019, 40(2): 142-158.
|
13. |
Li C, Long Q, Zhang D, et al. Identification of a four-gene panel predicting overall survival for lung adenocarcinoma. BMC Cancer, 2020, 20(1): 1198.
|
14. |
Sawaki K, Kanda M, Umeda S, et al. Level of melanotransferrin in tissue and sera serves as a prognostic marker of gastric cancer. Anticancer Res, 2019, 39(11): 6125-6133.
|
15. |
Ji L, Zhao G, Zhang P, et al. Knockout of MTF1 inhibits the epithelial to mesenchymal transition in ovarian cancer cells. J Cancer, 2018, 9(24): 4578-4585.
|
16. |
Anvari K, Pakdel AF, Memar B, et al. The prevalence and expression pattern of melanoma-associated antigen 1 in esophageal squamous cell carcinoma: A historical cohort study. Electron Physician, 2017, 9(2): 3756-3763.
|
17. |
Fanipakdel A, Seilanian Toussi M, Rezazadeh F, et al. Overexpression of cancer-testis antigen melanoma-associated antigen A1 in lung cancer: A novel biomarker for prognosis, and a possible target for immunotherapy. J Cell Physiol, 2019, 234(7): 12080-12086.
|
18. |
Liu Y, Cao M, Cai Y, et al. Dissecting the role of the FGF19-FGFR4 signaling pathway in cancer development and progression. Front Cell Dev Biol, 2020, 8: 95.
|
19. |
Chen J, Shao J, Shen A, et al. Enhanced expression of FGF19 predicts poor prognosis in patients with non-small cell lung cancer. J Thorac Dis, 2021, 13(3): 1769-1784.
|
20. |
Lang L, Teng Y. Fibroblast growth factor receptor 4 targeting in cancer: New Insights into mechanisms and therapeutic strategies. Cells, 2019, 8(1): 31.
|
21. |
Lee S, Choi J, Mohanty J, et al. Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling. Nature, 2018, 553(7689): 501-505.
|
22. |
Yang X, Liu Y, Li W, et al. DKK4-knockdown enhances chemosensitivity of A549/DTX cells to docetaxel. Acta Biochim Biophys Sin (Shanghai), 2017, 49(10): 899-906.
|
23. |
Lou X, Meng Y, Hou Y. A literature review on function and regulation mechanism of DKK4. J Cell Mol Med, 2021, 25(6): 2786-2794.
|
24. |
Huang SL, Chang TC, Chao CCK, et al. Role of the TLR4-androgen receptor axis and genistein in taxol-resistant ovarian cancer cells. Biochem Pharmacol, 2020, 177: 113965.
|